Quadrature Capital LTD Laboratory Corp Of America Holdings Transaction History

Quadrature Capital LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$209.01 - $232.56 $1.58 Million - $1.76 Million	7,571 New	7,571 $1.65 Billion
Q2 2021 Aug 16, 2021	SELL	$251.87 - $278.14 $604,488 - $667,536	-2,400 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$204.88 - $255.03 $1.33 Million - $1.66 Million	-6,492 Reduced 73.01%	2,400 $612,000
Q4 2020 Feb 16, 2021	BUY	$186.91 - $214.42 $669,511 - $768,052	3,582 Added 67.46%	8,892 $1.81 Million
Q2 2020 Aug 14, 2020	BUY	$113.31 - $182.44 $261,746 - $421,436	2,310 Added 77.0%	5,310 $883,000
Q1 2020 May 15, 2020	SELL	$104.32 - $195.28 $854,380 - $1.6 Million	-8,190 Reduced 73.19%	3,000 $380,000
Q4 2019 Feb 14, 2020	BUY	$163.48 - $173.61 $1.37 Million - $1.46 Million	8,390 Added 299.64%	11,190 $1.89 Million
Q1 2018 May 11, 2018	BUY	$161.53 - $178.11 $452,284 - $498,708	2,800 New	2,800 $0

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Quadrature Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Quadrature Capital LTD with notifications on news.